BeStock  
Stocks › Biotechnology › RAPP

Rapport Therapeutics RAPP

US equityMarket cap rank #2939Biotechnology
$23.16 −$0.43 (-1.82%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $23.16 0.00%
Open$23.23
Prev close$23.59
Day range$23.00 – $23.83
Volume437.7K
Market cap$1.37B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts14
Average target$68.00+193.6% vs. price
  • Buy 100%
Low $47.00Now $23.16Avg $68.00High $91.00

Recent rating changes

The last 20 actions on file set price targets from $47.00 to $91.00, averaging $65.17.

DateFirmRatingTarget
12 Nov 2026 JonesTrading BUY $82.00
5 Nov 2026 Wells Fargo BUY $47.00
5 Nov 2026 UBS BUY $64.00
5 Nov 2026 H.C. Wainwright BUY $63.00
4 Nov 2026 Wells Fargo BUY $47.00
4 Nov 2026 Guggenheim BUY $66.00
21 Oct 2026 Wells Fargo BUY $50.00
21 Oct 2026 JonesTrading BUY $82.00
21 Oct 2026 Goldman Sachs BUY $68.00
20 Oct 2026 Wells Fargo BUY $50.00
20 Oct 2026 Raymond James BUY $86.00
20 Oct 2026 Citizens JMP BUY $91.00
20 Oct 2026 Guggenheim BUY $70.00
20 Oct 2026 H.C. Wainwright BUY $66.00
16 Oct 2026 Wells Fargo BUY $51.00
15 Oct 2026 Wolfe Research BUY $50.00
5 Oct 2026 Guggenheim BUY $65.00
1 Oct 2026 BTIG BUY $75.00
23 Sep 2026 Raymond James BUY –
23 Sep 2026 Truist Financial BUY –

Discussion

No comments yet — be the first to weigh in on RAPP.

Sign in to join the discussion.

Scroll to Top